Bumetanide Injection
Product Images NDC 68083-497

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 68083-497). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton Label 10ml Fill)

Packaging label for Bumetanide Injection, USP 2.5 mg/10 mL (0.25 mg/mL) injection by Gland Pharma Limited. The label states the vial contains 10 x 10 mL multiple-dose vials for intravenous or intramuscular use. It includes storage instructions and warns that the container closure is not made with natural rubber latex.*

FDA Label Image

Carton (Carton Label 4ml Fill)

Packaging label for Bumetanide Injection, USP 1 mg/4 mL (0.25 mg/mL) injection, for intravenous or intramuscular use. The label specifies the product contains 10 vials of 4 mL single-dose. It is labeled for Rx only and manufactured by Gland Pharma Limited, Hyderabad, India.*

FDA Label Image

Container (Container Label 10ml Fill)

Bumetanide Injection, USP 0.25 mg/mL in a 10 mL multi-dose vial label. The injection is for intravenous or intramuscular use. The label lists active ingredient concentration and excipients, storage instructions, and states it contains benzyl alcohol as preservative. Manufactured by Gland Pharma Limited.*

FDA Label Image

Container (Container Label 4ml Fill)

Bumetanide Injection, USP 1 mg/4 mL (0.25 mg/mL) for intravenous or intramuscular use, containing benzyl alcohol. The label indicates a 4 mL single-dose vial from Gland Pharma Limited, Hyderabad, India. The label includes dosage instructions to see package insert and storage info, with a barcode and lot and expiration date fields.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Bumetanide showing its molecular components, including a benzene ring substituted with carboxylic acid (COOH), sulfonamide (SO2NH2), ethoxy group (OC2H5), and butylamino side group (CH3(CH2)3HN).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.